The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Assessing Atropisomer Axial Chirality in Drug Discovery and Development
Abstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTAssessing Atropisomer Axial Chirality in Drug Discovery and DevelopmentSteven R. LaPlante*†, Lee D. Fader†, Keith R. Fandrick‡, Daniel R. Fandrick‡, Oliver Hucke†, Ray Kemper‡, Stephen P. F. Miller§, and Paul J. Edwards*†View Author Information† Department of Chemistry, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec, H7S 2G5, Canada‡ Chemical Development, Non-Clinical Drug Safety, Boehringer Ingelheim Pharmaceutical Inc., 900 Ridgebury Road, Ridgefield, Connecticut 06877, United States§ Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 22, Room 1446, Silver Spring, Maryland 20993, United States*For S.R.L.: phone, 1-450-682-4640; fax, 1-450-682-8434; e-mail, [email protected]. For P.J.E.: phone, 1-450-682-4640; e-mail, [email protected]Cite this: J. Med. Chem. 2011, 54, 20, 7005–7022Publication Date (Web):August 17, 2011Publication History Received10 May 2011Published online15 September 2011Published inissue 27 October 2011https://pubs.acs.org/doi/10.1021/jm200584ghttps://doi.org/10.1021/jm200584greview-articleACS PublicationsCopyright © 2011 American Chemical SocietyRequest reuse permissionsArticle Views17317Altmetric-Citations577LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Chirality,Drug discovery,Mixtures,Molecular structure,Pharmaceuticals Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Challenge of Atropisomerism in Drug Discovery
Clayden, J., Moran, W. J., Edwards, P. J., & LaPlante, S. R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901719 · Cited by 783
Self-citationThe Significance of Chirality in Drug Design and Development
H. Brooks, W., C. Guida, W., & G. Daniel, K. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795165098 · Cited by 694
Putting chirality to work: the strategy of chiral switches
Agranat, I., Caner, H., & Caldwell, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd915 · Cited by 637
Revealing Atropisomer Axial Chirality in Drug Discovery
LaPlante, S. R., Edwards, P. J., Fader, L. D., Jakalian, A., & Hucke, O. (2011) · ChemMedChem · doi:10.1002/cmdc.201000485 · Cited by 535
Self-citationShen, X., Jones, G. O., Watson, D. A., Bhayana, B., & Buchwald, S. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja104297g · Cited by 288
Comi, G., Pulizzi, A., Rovaris, M., Abramsky, O., Arbizu, T., Boiko, A., Gold, R., Havrdova, E., Komoly, S., Selmaj, K., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60918-6 · Cited by 278
Eriksson, T., Bjöurkman, S., Roth, B., Fyge, Å., & Höuglund, P. (1995) · Chirality · doi:10.1002/chir.530070109 · Cited by 251
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS
Polman, C., Barkhof, F., Sandberg-Wollheim, M., Linde, A., Nordle, O., & Nederman, T. (2005) · Neurology · doi:10.1212/01.wnl.0000154520.48391.69 · Cited by 227
Toxicity and Teratogenicity of Optical Isomers of Thalidomide
FABRO, S., SMITH, R. L., & WILLIAMS, R. T. (1967) · Nature · doi:10.1038/215296a0 · Cited by 200
Are Oral Contraceptives a Significant Contributor to the Estrogenicity of Drinking Water?
Wise, A., O’Brien, K., & Woodruff, T. (2011) · Environmental Science & Technology · doi:10.1021/es1014482 · Cited by 150
Reist, M., Carrupt, P., Francotte, E. R., & Testa, B. (1998) · Chemical Research in Toxicology · doi:10.1021/tx9801817 · Cited by 145
Tagat, J. R., McCombie, S. W., Nazareno, D. V., Labroli, M. A., Xiao, Y., Steensma, R. W., Strizki, J., Baroudy, B. M., Cox, K., Lachowicz, J. E., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0304515 · Cited by 137
Chiral Polychlorinated Biphenyl Transport, Metabolism, and Distribution: A Review
Lehmler, H., Harrad, S. J., Hühnerfuß, H., Kania‐Korwel, I., Lee, C. M., Lu, Z., & Wong, C. S. (2009) · Environmental Science & Technology · doi:10.1021/es902208u · Cited by 134
WELCH, W. M., Ewing, F. E., HUANG, J., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00622-3 · Cited by 125
Chirality and the biological activity of drugs
Crossley, R. J. (1995) · Cited by 119
Clayden, J. (2004) · Chemical Communications · doi:10.1039/b307976g · Cited by 114
Stereochemical aspects of drug action and disposition
Eichelbaum, M. F., & Gross, A. S. (2003) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.1016/s0065-2490(96)80003-7 · Cited by 107
Scalable Total Synthesis and Biological Evaluation of Haouamine A and Its Atropisomer
Burns, N. Z., Krylova, I. N., Hannoush, R. N., & Baran, P. S. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903745s · Cited by 102
Afzelius, L., Zamora, I., Ridderström, M., Andersson, T. B., Karlén, A., & Masimirembwa, C. M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09261-7 · Cited by 98
Metabolic stereoisomeric inversion of ibuprofen in mammals
Chen, C., Shieh, W.-R., Lu, P.-H., Harriman, S. P., & Chen, C.-Y. (1991) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(91)90164-u · Cited by 96
Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists
Palani, A., & Tagat, J. R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060009x · Cited by 85
Muniz-Medina, V. M., Jones, S. A., Maglich, J. M., Galardi, C. M., Hollingsworth, R. E., Kazmierski, W. M., Ferris, R. G., EDELSTEIN, M. P., Chiswell, K., & Kenakin, T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052555 · Cited by 78
Removal of Iodinated X-Ray Contrast Media During Drinking Water Treatment
Seitz, W., Jiang, J., Weber, W. H., et al. (2006) · Environmental Chemistry · doi:10.1071/en05036 · Cited by 70
Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A.
Tracy, T. S., & Hall, S. D. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08607-6 · Cited by 65
McCombie, S. W., Tagat, J. R., Vice, S. F., Lin, S., Steensma, R. W., Palani, A., Neustadt, B. R., Baroudy, B. M., Strizki, J., Endres, M. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00918-6 · Cited by 52
Clearance of Polychlorinated Biphenyl Atropisomers is Enantioselective in Female C57Bl/6 Mice
Kania‐Korwel, I., Elkomy, M. H., Veng‐Pedersen, P., & Lehmler, H. (2009) · Environmental Science & Technology · doi:10.1021/es901781p · Cited by 42
Shah, R. R., Midgley, J., & Branch, S. K. (1999) · PubMed · Cited by 42
Palani, A., Shapiro, S., Clader, J. W., Greenlee, W. J., Vice, S. F., McCombie, S. W., Cox, K., Strizki, J., & Baroudy, B. M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01063-6 · Cited by 35
Palani, A., Shapiro, S., Clader, J. W., Greenlee, W. J., Blythin, D. J., Cox, K., Wagner, N., Strizki, J., Baroudy, B. M., & Dan, N. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01062-4 · Cited by 31
Deur, C., Agrawal, A. K., Baum, H., Booth, J., Bove, S. E., Brieland, J. K., Bunker, A. M., Connolly, C. J. C., Cornicelli, J. A., Dumin, J., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.083 · Cited by 24
Gao, W., & Kang, J. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.12.102 · Cited by 18
Cited by
Kumarasamy, E., Raghunathan, R., Sibi, M. P., & Sivaguru, J. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00136 · Cited by 756
Discovery of a Covalent Inhibitor of KRAS G12C (AMG 510) for the Treatment of Solid Tumors
Lanman, B. A., Allen, J. R., Allen, J. G., Amegadzie, A. K., Ashton, K. S., Booker, S. K., Chen, J. J., Chen, N., Frohn, M. J., Goodman, G., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01180 · Cited by 765
Atropisomerism in Medicinal Chemistry: Challenges and Opportunities
Toenjes, S. T., & Gustafson, J. L. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0152 · Cited by 382
General Enantioselective C−H Activation with Efficiently Tunable Cyclopentadienyl Ligands
Jia, Z., Merten, C., Gontla, R., Daniliuc, C. G., Antonchick, A. P., & Waldmann, H. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611981 · Cited by 336
Atropisomerism in the Pharmaceutically Relevant Realm
Basilaia, M., Chen, M. H., Secka, J., & Gustafson, J. L. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.2c00500 · Cited by 326
Metadata
- Authors
- LaPlante, S. R., Fader, L. D., Fandrick, K. R., Fandrick, D. R., Hucke, O., Kemper, R., Miller, S. P. F., & Edwards, P. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-09-15
- Volume
- 54
- Issue
- 20
- Pages
- 7005-7022
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2335442430
- Cited by
- 861
- References
- 31
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.